INTERCEPT at UEG Week 2026: Advancing Crohn’s Disease Prediction and Prevention
INTERCEPT had a strong presence at UEG Week 2026 in Barcelona, contributing to discussions on the future of Crohn’s disease prediction and prevention, patient involvement and collaborative European research. A key highlight was the INTERCEPT Stakeholder Workshop, which brought together different perspectives to explore how advances in research can translate into clinical practice.
Bringing stakeholder perspectives into Crohn’s disease prediction and prevention
Held on 19 October, the INTERCEPT Stakeholder Workshop brought together patients, first-degree relatives of people with Crohn’s disease, clinicians and project experts to discuss the opportunities and challenges of moving Crohn’s disease prediction and prevention from research into clinical practice.
The discussion addressed key topics such as predictive testing, risk communication, clinical utility and the practical challenges of implementing prevention strategies.
Speakers included Prof. Dr. Geert D’Haens, INTERCEPT Project Coordinator, Prof. Jean-Frédéric Colombel, INTERCEPT Co-Lead Principal Investigator, and Dr. Joana Torres, PREDICT-CD Study Coordinator. Dr. Torres highlighted the innovative nature of INTERCEPT and how the project represents a new approach to predicting and potentially preventing Crohn’s disease.
Moderated by Luisa Avedano, CEO of IFCCA, an INTERCEPT project partner, the workshop placed particular emphasis on the perspectives of patients and first-degree relatives. IFCCA representatives Roberto Saldaña and Vaso Vakouftsi stressed that early diagnosis must be accompanied by clear guidance, support and potential treatment options. As highlighted during the discussion, “patients are open to early diagnosis, as long as potential solutions and treatment options are presented alongside the diagnosis.”
The workshop reinforced the importance of involving those directly affected by Crohn’s disease in shaping prevention strategies that are not only scientifically robust but also meaningful and applicable in real-world healthcare settings.
INTERCEPT across UEG Week 2026
Beyond the Stakeholder Workshop, INTERCEPT contributed to two additional activities at UEG Week.
During the UEG Community Programme, Dr. Joana Torres and Prof. Jean-Frédéric Colombel participated in a practical session moderated by Ignacio Catalán-Serra on developing research proposals, planning early-stage projects and building consortia for EU funding opportunities. The session also featured Henrich Hipca, who introduced the UEG Project Start-Up Grant, which supports the preparation of Horizon Europe proposals.
INTERCEPT was also represented at the Nutrition Hub’s “Meet the Experts” session, where Dr. Joana Torres discussed the potential of Crohn’s disease prevention and introduced the project to participants. Organised with the involvement of the GI Nutrition Foundation, the session provided another opportunity to raise awareness of INTERCEPT and its approach to disease prediction and prevention.
Together, these activities highlighted INTERCEPT’s commitment to advancing Crohn’s disease prediction and prevention through scientific collaboration, stakeholder engagement and patient-centred research, while strengthening the project’s visibility within the European gastroenterology community.



